One step at a time: Identification and validation of biomarkers for nonalcoholic steatohepatitis
Jayant A. Talwalkar – 28 September 2009
Endotoxemia in alcoholic liver disease
Tetsuji Fujita – 28 September 2009
Comments on minimizing misdiagnosis of hepatocellular carcinoma from magnetic resonance imaging
Yun Ku Cho – 28 September 2009
Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss
Nathan A. Johnson, Toos Sachinwalla, David W. Walton, Kate Smith, Ashley Armstrong, Martin W. Thompson, Jacob George – 28 September 2009 – Weight loss remains the most common therapy advocated for reducing hepatic lipid in obesity and nonalcoholic fatty liver disease. Yet, reduction of body weight by lifestyle intervention is often modest, and thus, therapies which effectively modulate the burden of fatty liver but are not contingent upon weight loss are of the highest practical significance.
Targeting liver fibrosis: Strategies for development and validation of antifibrotic therapies
Yury Popov, Detlef Schuppan – 28 September 2009 – We have made striking progress in our understanding of the biochemistry and cell biology that underlies liver fibrosis and cirrhosis, including the development of strategies and agents to prevent and reverse fibrosis.
Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver
Anne T. Nies, Hermann Koepsell, Stefan Winter, Oliver Burk, Kathrin Klein, Reinhold Kerb, Ulrich M. Zanger, Dietrich Keppler, Matthias Schwab, Elke Schaeffeler – 28 September 2009 – An important function of hepatocytes is the biotransformation and elimination of various drugs, many of which are organic cations and are taken up by organic cation transporters (OCTs) of the solute carrier family 22 (SLC22).
Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen–restricted immune pressure
Andri Rauch, Ian James, Katja Pfafferott, David Nolan, Paul Klenerman, Wendy Cheng, Lindsay Mollison, Geoff McCaughan, Nick Shackel, Gary P. Jeffrey, Ross Baker, Elizabeth Freitas, Isla Humphreys, Hansjakob Furrer, Huldrych F. Günthard, Bernard Hirschel, Simon Mallal, Mina John, Michaela Lucas, Eleanor Barnes, Silvana Gaudieri – 28 September 2009 – Many hepatitis C virus (HCV) infections worldwide are with the genotype 1 and 3 strains of the virus.
Incidence, risk factors, and survival of hepatocellular carcinoma in primary biliary cirrhosis: Comparative analysis from two centers
Anna Cavazza, Llorenç Caballería, Annarosa Floreani, Fabio Farinati, Miquel Bruguera, Diego Caroli, Albert Parés – 28 September 2009 – The limited information and divergent results on the prevalence, incidence, and risk factors for hepatocellular carcinoma (HCC) in patients with primary biliary cirrhosis (PBC) may be due to the low prevalence of the disease and geographical and environmental differences.
Management of adult patients with ascites due to cirrhosis: An update
Bruce A. Runyon – 28 September 2009
Overexpression of far upstream element binding proteins: A mechanism regulating proliferation and migration in liver cancer cells
Mona Malz, Achim Weber, Stephan Singer, Vera Riehmer, Michaela Bissinger, Marc‐Oliver Riener, Thomas Longerich, Christopher Soll, Arndt Vogel, Peter Angel, Peter Schirmacher, Kai Breuhahn – 28 September 2009 – Microtubule‐dependent effects are partly regulated by factors that coordinate polymer dynamics such as the microtubule‐destabilizing protein stathmin (oncoprotein 18). In cancer cells, increased microtubule turnover affects cell morphology and cellular processes that rely on microtubule dynamics such as mitosis and migration.